Neoplastic Syndrome Completed Phase 2 Trials for Thalidomide (DB01041)

Also known as: Neoplastic disease (disorder)

IndicationStatusPhase
DBCOND0028594 (Neoplastic Syndrome)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00027638Thalidomide in Treating Patients With Metastatic Neuroendocrine TumorsTreatment